Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.

Benzer Materyaller

• Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters
  Yazar:: Dutta, Aloke K., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?
  Yazar:: Sharma, Horrick, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template
  Yazar:: Santra, Soumava, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol : Synthesis, biological characterization, and development of a pharmacophore model
  Yazar:: Sharma, Horrick, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Structural Exploration of (3S,6S)-6-Benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine Analogues: Identification of Potent Triple Monoamine Reuptake Inhibitors as Potential Antidepressants
  Yazar:: Santra, Soumava, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)